• Теги
    • избранные теги
    • Компании802
      • Показать ещё
      Разное102
      • Показать ещё
      Страны / Регионы107
      • Показать ещё
      Международные организации13
      Показатели19
      • Показать ещё
      Формат4
      Люди9
      • Показать ещё
      Сферы1
      Издания1
Biogen Idec
10 мая, 16:00

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

We have all seen or heard of high-profile cases where M&A deals didn’t work out. AOL–Time Warner, HP-Compaq, Quaker-Snapple — these are just some of the big ones. An analysis of 2,500 such deals by our firm shows that more than 60% of them destroy shareholder value. Perhaps such deals should come with an official warning: “Acquisitions can result in serious damage to your corporate health, up to and including death.” And yet even in light of such daunting data, many corporate leaders feel compelled to pursue growth through M&A, figuring the risks of inaction are just as high. After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. As our research has shown us, the core of the problem is not the high number of M&A deals in itself, but rather that too many executives bring insufficient discipline to the evaluation process that fuels these deals — as a result, they often get deals wrong. For instance, despite the importance of accurately identifying and calculating company synergies, diligence work frequently results in an overly optimistic view of the revenue synergy opportunity. Often the weakest assumptions involve estimates of how much additional revenue the companies can generate when combined. This, in turn, leads bidders to overpay. Our experience with many global companies across industries and sectors has revealed a framework for pursuing growth through acquisition that lowers risks and helps beat the odds. As we’ve written previously, the best path to accelerated growth with limited risk often comes from creating new products and services that leverage a company’s existing resources, customers, and capabilities. In the course of research for our book, we’ve found that this approach also provides an ideal methodology for leaders to identify which M&A deals are most likely to pay off — a disciplined approach that acts as a kind of lens for effectively distinguishing gold from iron pyrite in assessing potential company synergies. Helping customers complete their “journey” An example of a stunningly successful merger was Procter & Gamble’s 2005 acquisition of Gillette. While some cost synergies were realized, the real payoff came because each company independently recognized that it had the permission to expand what it was offering to its core customers and that the capabilities to deliver on this potential resided in the other company. Gillette dominated the men’s shaving market with its Mach series of razors. P&G was able to combine Mach blade technology with its women’s skin care expertise to market women’s shaving products under the Gillette Venus brand. Gillette introduced new shave lotions, deodorants, and shower gels for men using P&G’s soap, lotion, and antiperspirant technology and expertise. These acquisition synergies worked because they leverage what we call a “journey edge” — a place where current offerings can be expanded in subtle but logical ways along the fuzzy demarcation between existing product definition and customer receptivity. In accessing this type of opportunity, there is the challenge, “What permission would customers give us to extend our role in helping them to achieve their ultimate mission?” Gillette felt it had permission from its razor customers to offer them a bit more to support their ultimate mission of getting a great shave. Contrast this with another well-known deal: When eBay bought Skype, eBay executives implicitly thought that video chat belonged somewhere on the journey their customers experienced, and that eBay would be granted permission to offer this extension to its core offering. The reality was that most customers didn’t see a need for video chat to conduct online auctions, and if they did, they didn’t feel they needed eBay to provide it for them. In part, the deal failed because the combination wasn’t welcomed as a way to better complete an important customer journey. By more rigorously mapping the journey and testing the premise of customer permissions, eBay might have seen that the cross-selling synergy was not as robust as thought. Testing where else your foundational assets will work Edge mindset and discipline can also increase the likelihood of a merger paying off by capitalizing on latent capabilities or underutilized assets of the combining companies. This is the discipline behind what we term “enterprise edges,” where we ask, “Who besides a competitor would pay to access my assets?” This thinking helps identify new revenue streams for a business by challenging where else assets that have been assembled to serve our core business could be utilized. To test this framework in the M&A context, we ask, “In the absence of a deal, would the acquiree pay for access to my assets?” This relatively simple approach is actually a powerful tool to help confirm or deny the potential for synergies. The rationale for this approach is highlighted when you compare, for example, the different approaches to M&A employed by a number of legacy pharmaceutical companies and by some relatively newer players in the biotechnology industry. We have all seen big pharma deals in which companies were eager to find large sources of revenue growth to fill their pipelines and to meet ongoing shareholder expectations, making major acquisitions in order to access blockbuster ($1 billion or more) drugs developed by other companies. However, this approach to seeking growth often saddled these companies with unwieldy portfolios of additional assets, many of which had to be unloaded at discounts to the original premiums paid (in other words, technologies they didn’t have the expertise to cultivate and markets they didn’t fully know how to commercialize). By contrast, some of the key players in biotech (Biogen Idec, Amgen, Genentech) have tended to take a more disciplined approach. For example, Gilead grew from a tiny startup developing H.I.V. therapy to a major drug company with $30 billion in annual revenue by successfully deploying what we would call an “edge strategy” approach to M&A. It was propelled by a series of disciplined acquisitions, mainly of companies with drugs for other infectious diseases, such as Hepatitis B and Hepatitis C. In other words, Gilead capitalized on a key foundational asset — its deep expertise in developing and marketing an antiviral franchise — and used this to pressure-test where else this capability could be put to work. While one can’t make a specific claim of causation related to these approaches, we believe it has helped lead to Gilead’s strong performance over the past 15 years, which significantly outpaced the broader Pharma index, and that it has played a part in the biotech sector’s remarkable growth over the same period. Ultimately, the key is discipline. By rigorously and relentlessly asking two questions — “How will the deal help our customers to complete their journey?” and “How is the deal using our foundational assets to create value in a different context?” — an edge strategy approach to M&A can mitigate the risks of an inherently risky business.

21 апреля, 17:17

Biogen (BIIB) Tops on Q1 Earnings, Slight Revenue Miss

Biogen's (BIIB) first-quarter earnings were well above expectations though Tecfidera revenues declined sequentially.

27 января, 19:35

Biogen Tops on Q4 Earnings by a Wide Margin, Provides View

Biogen's (BIIB) fourth quarter earnings shot past expectations with Tecfidera improving sequentially.

21 октября 2015, 18:40

Biogen Tops Q3 Earnings, Announces Job Cuts, Ups View

Biogen (BIIB) surpassed Q3 earnings expectations by a wide margin.

16 октября 2015, 17:10

Stock Market News for October 16, 2015

Benchmarks surged on Thursday to end in the green following strong gains in financial stocks and easing rate hike fears

04 сентября 2015, 18:02

Right Time to Buy Franklin DynaTech A Fund (FKDNX)

Right Time to Buy Franklin DynaTech A Fund (FKDNX)

14 августа 2015, 05:42

The New Equality Act: Every Great Company Should Step Up Now and Support this Legislation

A recent LGBT victory in the US Supreme Court brought marriage equality to every state in our nation. But it still comes as news to many Americans that if you are gay, you can still be fired in many jurisdictions in this country. Gaining such protection has eluded the LGBT community for decades. So, now that we can marry, we can still be fired if we display the wedding pictures on our desk. Thirty-one (31) states still lack fully inclusive non-discrimination protections for LGBT people. Recently, the new federal Equality Act was introduced in Congress by Senators Jeff Merkley, Tammy Baldwin, and Cory Booker; and Representatives David Cicilline and John Lewis. According to the Human Rights Campaign, the bill: ... establishes explicit, permanent protections against discrimination based on an individual's sexual orientation or gender identity in matters of employment, housing, access to public places, federal funding, credit, education and jury service. In addition, it would prohibit discrimination on the basis of sex in federal funding and access to public places. Voters overwhelmingly support these basic protections for LGBT Americans. According to recent polling released by HRC, 78 percent of likely voters support workplace non-discrimination protections. This includes support from 90 percent of likely Democratic voters, two-thirds (64 percent) of likely Republican voters, and 70 percent of observant Christians. Moreover, nearly 60 percent of voters are less likely to support a candidate who doesn't support such protections for LGBT people, including 61 percent of Independent voters and 58 percent of Catholic voters. (HRC, August 2015.) In the overall journey to achieve basic civil rights for LGBT Americans, Corporate America has been an unlikely hero. The Fortune 1000, as well as many other institutions, have implemented various aspects of LGBT workplace non-discrimination policies at a breathtaking speed over the past couple of decades. However, despite such progress, the policies vary from company to company and do not provide uniform baseline protection for LGBT workers. Last week, Intel Corporation joined a growing number of American companies (including Amazon, American Airlines, Apple, Facebook, General Electric, General Mills, Google, HP, IBM, Levi Strauss & Co, Microsoft, Nike, Oracle, Orbitz, Symantec Corporation and the Dow Chemical Company) in support of the Equality Act. While this is a good start, this list is dwarfed by the hundreds of companies that have achieved high scores on the HRC Corporate Equality Index. Supporting the Equality Act should be a simple matter for most corporate government affairs department. It is simply making manifest a standard many of the best corporation in this country have adopted long ago. In the case of Windsor vs. United States, hundreds of companies signed on to an Amicus Brief in the Supreme Court of Windsor vs. the United States, a case that struck down Section 3 of the Defense of Marriage Act. If companies can support striking down an oppressive federal law, surely they can support erecting a fair one. (Listed below are the companies, law firms, municipalities and other institutions that signed onto that amicus brief.) The sooner these and hundreds more companies get on board, the faster this common sense legislation can be passed. And when Congress passes the Equality Act, it will finally join the 20th Century in promoting the best in workplace practices. *Entities that signed on to Amicus Brief: Addis Creson Adobe Systems Inc. Aetna Inc. Aggregate Supply Akamai Technologies, Inc. Alaska Air Group, Inc. Alaska Airlines Alcoa Inc. Alere Inc. Amazon.com, Inc. American International Group, Inc. (AIG) Ameristar Casinos, Inc. Apple Inc. AppNexus Inc. ARC Design Artify, Inc. Avanade Inc. A|X Armani Exchange, LLC Bain & Company, Inc. The Bank of New York Mellon Corporation (BNY Mellon) Bankers Trust Co. Big Duck Studio, Inc. Bigelow Villa LLC Biogen Idec, Inc. BlackRock, Inc. Blu Homes, Inc. Blue Cross Blue Shield of Massachusetts, Inc. Boehringer Ingelheim USA Corporation Borrego Solar Systems Inc. Boston Community Capital, Inc. The Boston Foundation Boston Medical Center Corporation Boston Scientific Corporation The Bridgespan Group Broadcom Corporation Caesars Entertainment Corporation Car Toys, Inc. CBS Corporation Central Physical Therapy and Fitness, Inc. Chang Consulting Cisco Systems, Inc. Citigroup Inc. City Catering Company City Lites Neon, Inc. Clean Yield Asset Management Commune Hotels & Resorts Conlin Properties, Inc. The Corcoran Group Coupons.com Inc. Crazy Misfits Pet Services Credit Suisse Securities (USA) LLC Credit Suisse Securities (USA) LLC Dana-Farber Cancer Institute, Inc. David Kosar Insurance Agency Depository Trust & Clearing Corporation DesignWorlds for Learning, Inc. Deutsche Bank AG Diageo North America, Inc. Distinguished Gay Men DML Insurance Services, Inc. Dry Creek Vineyard DRY Soda Co. Eastern Bank Corporation eBay Inc. Eldercare Consulting Electronic Arts Inc. EMC Corporation EnduringHydro, LLC Ernst & Young LLP Exelon Corporation Facebook, Inc. Firefly Creative Co. 500 BC, Inc. Flanery CPA The Forward Motion Group, LLC Full Court Press Communications Gammelgården, LLC Gardenworks Inc. Geolo Capital, Inc. Gilt Groupe Holdings, Inc. Go Factory, LLC The Goldman Sachs Group, Inc. Google Inc. Greensulate Grossman Marketing Group Group Health Cooperative Hafner Vineyard Harrell Remodeling Holdredge Wines Homeward Pet Adoption Center Horizon Air Industries, Inc. ID Financial, LLC Inspirato, LLC Integrated Archive Systems, Inc. Intel Corporation Intuit Inc. INUS Group, LLC iStrategyLabs Jackson Hole Group LLC James D. Wood, DDS Family Dental Care Jazz Pharmaceuticals, Inc. JetBlue Airways Corporation The Jim Henson Company Johnson & Johnson Jo-Lynn Otto Photography JTracz Designs LLC Kemp Goldberg Partners Kimpton Hotel & Restaurant Group, LLC Kinzer Real Estate Kollmar Sheet Metal Works, Inc. Kotzan Chiropractic Laparoscopic Institute for Gynecologic Oncology Larson Marketing & Communications LLC Levi Strauss & Co. Liberty Mutual Group Inc. Loring, Wolcott & Coolidge Trust, LLC M. Arthur Gensler Jr. & Associates, Inc. Marriott International, Inc. Mars, Incorporated Marsh & McLennan Companies Massachusetts Association of Health Plans Massachusetts Mutual Life Insurance Co. Mattson The McGraw-Hill Companies McKinstry Co. Microsoft Corporation Moody's Corporation Morgan Stanley Mosaic Financial Partners, Inc. MultiPlan, Inc. Neumann Capital Management, LLC New York Life Insurance Company NIKE, Inc. The Ogilvy Group, Inc. The Olivia Companies, LLC 1 Source Consulting Solutions Onyx Pharmaceuticals, Inc. Oracle America, Inc. Orbitz Worldwide Partners HealthCare System, Inc. Paul's Draperies, Inc. Pfizer Inc. Pierson Labs Planet Fitness Precision Door Service The PrintingWorks Prior Construction Pro-Tec Data, Inc. ProTrials Research, Inc. Puma Spring Vineyards Qualcomm Incorporated Ray Holley Communications Recreational Equipment, Inc. (REI) Regroup Reproductive Science Center of New England, P.C. Resource Systems Group, Inc. (RSG) Rising Tide Brewing Company RLL Consulting & Advocacy, LLC Rocket Science Associates Rural Communications Service Corporation salesforce.com, Inc. Seabold International Services LLC Seattle Hospitality Group LLC The Seattle Lesbian, LLC Shawmut Design and Construction Silicon Valley Progressive Faith Community Sing Out Louise! Productions Smith & Quinn LLC Solutions Wealth Management, LLC Sōw Starbucks Corporation State Street Corporation Stone Way Eateries, LLC Stonyfield Farm, Inc. Stuffed Cakes, LLC Sun Life Financial (U.S.) Service Stonyfield Farm, Inc. Stuffed Cakes, LLC Sun Life Financial (U.S.) Services Company, Inc. Support.com Sweet Taber Food Services, Inc. Thomson Reuters Total Awareness Accounting Services Total Home Improvement Inc. Transparent Language, Inc. Twitter, Inc. 206 Inc. UBS AG U.S. Balloon Co. The Ultimate Software Group, Inc. Unigo LLC VCB Consulting & Accounting Services Velsch Unlimited LLC Verity Credit Union Viacom Inc. VitalSource Staffing, LLC Vulcan Inc. W/S Development Associates LLC Walt Disney Company Wasserman Media Group Windows Management Experts, Inc. Witeck Communications, Inc. Xerox Corporation Zynga Inc. Law and professional firms: A.L. Nella & Company, LLP, CPAs Axcel Law Partners LLP Baker & McKenzie LLP Burns & Levinson LLP Choate Hall & Stewart LLP Davis, Brown, Koehn, Shors & Roberts, P.C. DLK Law Group, P.C. Edwards Wildman Palmer LLP Farella Braun + Martel, LLP Fenwick & West LLP Goulston & Storrs, P.C. Grippo & Elden LLC Heath-Newton LLP Hughes Hubbard & Reed LLP Integrity Law Group Jennifer Brown Consulting Jonathan L. Bowman, Attorney at Law, PS Kazan, McClain, Satterley, Lyons, Greenwood & Oberman, PLC Keker & Van Nest LLP Lafayette & Kumagai LLP Law Office of Lisa E. Schuchman The Law Office of Susan K. Fuller, PLLC Law Offices of Cynthia F. Buhr PLLC Lieff Cabraser Heimann & Bernstein, LLP Mona Smith PLLC Nixon Peabody LLP Peabody & Arnold LLP Prince Lobel Tye LLP Public Interest Law Group, PLLC Ropes & Gray LLP Russell & Olson, LLP Salera Consulting Seyfarth Shaw LLP Shearman & Sterling LLP Skadden, Arps, Slate, Meagher & Flom LLP Skellenger Bender, P.S. Spectra Law PS Valdez Noor Todd & Doyle LLP Venable LLP Willkie Farr & Gallagher LLP Professional, trade, and civic organizations: American Benefits Council Connecticut Alliance for Business Opportunities Golden Gate Restaurant Association Greater Boston Chamber of Commerce Greater San Diego Business Association Greater Seattle Business Association Long Beach Community Business Network Massachusetts Teachers Association The National Fire Protection Association, Inc. National Gay and Lesbian Chamber of Commerce Out & Equal Workplace Advocates Portland Area Business Association Rainbow Chamber of Commerce Silicon Valley San Francisco Chamber of Commerce Seattle Metropolitan Chamber of Commerce StartOut and Cities, Counties and the United States Conference of Mayors: The City of Baltimore, Maryland The City of Bangor, Maine The City of Boston, Massachusetts The City of Cambridge, Massachusetts The City of Hartford, Connecticut The City of Healdsburg, California The City of Los Angeles, California The City of New York, New York, and the Council of the City of New York, New York The City of Northampton, Massachusetts The City of Portsmouth, New Hampshire The City of Providence, Rhode Island The City and County of San Francisco, California The City of Santa Monica, California The City of Seattle, Washington The City of West Hollywood, California The County of King, Washington The County of Santa Clara, California The United States Conference of Mayors -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

14 августа 2015, 05:42

The New Equality Act: Every Great Company Should Step Up Now and Support this Legislation

A recent LGBT victory in the US Supreme Court brought marriage equality to every state in our nation. But it still comes as news to many Americans that if you are gay, you can still be fired in many jurisdictions in this country. Gaining such protection has eluded the LGBT community for decades. So, now that we can marry, we can still be fired if we display the wedding pictures on our desk. Thirty-one (31) states still lack fully inclusive non-discrimination protections for LGBT people. Recently, the new federal Equality Act was introduced in Congress by Senators Jeff Merkley, Tammy Baldwin, and Cory Booker; and Representatives David Cicilline and John Lewis. According to the Human Rights Campaign, the bill: ... establishes explicit, permanent protections against discrimination based on an individual's sexual orientation or gender identity in matters of employment, housing, access to public places, federal funding, credit, education and jury service. In addition, it would prohibit discrimination on the basis of sex in federal funding and access to public places. Voters overwhelmingly support these basic protections for LGBT Americans. According to recent polling released by HRC, 78 percent of likely voters support workplace non-discrimination protections. This includes support from 90 percent of likely Democratic voters, two-thirds (64 percent) of likely Republican voters, and 70 percent of observant Christians. Moreover, nearly 60 percent of voters are less likely to support a candidate who doesn't support such protections for LGBT people, including 61 percent of Independent voters and 58 percent of Catholic voters. (HRC, August 2015.) In the overall journey to achieve basic civil rights for LGBT Americans, Corporate America has been an unlikely hero. The Fortune 1000, as well as many other institutions, have implemented various aspects of LGBT workplace non-discrimination policies at a breathtaking speed over the past couple of decades. However, despite such progress, the policies vary from company to company and do not provide uniform baseline protection for LGBT workers. Last week, Intel Corporation joined a growing number of American companies (including Amazon, American Airlines, Apple, Facebook, General Electric, General Mills, Google, HP, IBM, Levi Strauss & Co, Microsoft, Nike, Oracle, Orbitz, Symantec Corporation and the Dow Chemical Company) in support of the Equality Act. While this is a good start, this list is dwarfed by the hundreds of companies that have achieved high scores on the HRC Corporate Equality Index. Supporting the Equality Act should be a simple matter for most corporate government affairs department. It is simply making manifest a standard many of the best corporation in this country have adopted long ago. In the case of Windsor vs. United States, hundreds of companies signed on to an Amicus Brief in the Supreme Court of Windsor vs. the United States, a case that struck down Section 3 of the Defense of Marriage Act. If companies can support striking down an oppressive federal law, surely they can support erecting a fair one. (Listed below are the companies, law firms, municipalities and other institutions that signed onto that amicus brief.) The sooner these and hundreds more companies get on board, the faster this common sense legislation can be passed. And when Congress passes the Equality Act, it will finally join the 20th Century in promoting the best in workplace practices. *Entities that signed on to Amicus Brief: Addis Creson Adobe Systems Inc. Aetna Inc. Aggregate Supply Akamai Technologies, Inc. Alaska Air Group, Inc. Alaska Airlines Alcoa Inc. Alere Inc. Amazon.com, Inc. American International Group, Inc. (AIG) Ameristar Casinos, Inc. Apple Inc. AppNexus Inc. ARC Design Artify, Inc. Avanade Inc. A|X Armani Exchange, LLC Bain & Company, Inc. The Bank of New York Mellon Corporation (BNY Mellon) Bankers Trust Co. Big Duck Studio, Inc. Bigelow Villa LLC Biogen Idec, Inc. BlackRock, Inc. Blu Homes, Inc. Blue Cross Blue Shield of Massachusetts, Inc. Boehringer Ingelheim USA Corporation Borrego Solar Systems Inc. Boston Community Capital, Inc. The Boston Foundation Boston Medical Center Corporation Boston Scientific Corporation The Bridgespan Group Broadcom Corporation Caesars Entertainment Corporation Car Toys, Inc. CBS Corporation Central Physical Therapy and Fitness, Inc. Chang Consulting Cisco Systems, Inc. Citigroup Inc. City Catering Company City Lites Neon, Inc. Clean Yield Asset Management Commune Hotels & Resorts Conlin Properties, Inc. The Corcoran Group Coupons.com Inc. Crazy Misfits Pet Services Credit Suisse Securities (USA) LLC Credit Suisse Securities (USA) LLC Dana-Farber Cancer Institute, Inc. David Kosar Insurance Agency Depository Trust & Clearing Corporation DesignWorlds for Learning, Inc. Deutsche Bank AG Diageo North America, Inc. Distinguished Gay Men DML Insurance Services, Inc. Dry Creek Vineyard DRY Soda Co. Eastern Bank Corporation eBay Inc. Eldercare Consulting Electronic Arts Inc. EMC Corporation EnduringHydro, LLC Ernst & Young LLP Exelon Corporation Facebook, Inc. Firefly Creative Co. 500 BC, Inc. Flanery CPA The Forward Motion Group, LLC Full Court Press Communications Gammelgården, LLC Gardenworks Inc. Geolo Capital, Inc. Gilt Groupe Holdings, Inc. Go Factory, LLC The Goldman Sachs Group, Inc. Google Inc. Greensulate Grossman Marketing Group Group Health Cooperative Hafner Vineyard Harrell Remodeling Holdredge Wines Homeward Pet Adoption Center Horizon Air Industries, Inc. ID Financial, LLC Inspirato, LLC Integrated Archive Systems, Inc. Intel Corporation Intuit Inc. INUS Group, LLC iStrategyLabs Jackson Hole Group LLC James D. Wood, DDS Family Dental Care Jazz Pharmaceuticals, Inc. JetBlue Airways Corporation The Jim Henson Company Johnson & Johnson Jo-Lynn Otto Photography JTracz Designs LLC Kemp Goldberg Partners Kimpton Hotel & Restaurant Group, LLC Kinzer Real Estate Kollmar Sheet Metal Works, Inc. Kotzan Chiropractic Laparoscopic Institute for Gynecologic Oncology Larson Marketing & Communications LLC Levi Strauss & Co. Liberty Mutual Group Inc. Loring, Wolcott & Coolidge Trust, LLC M. Arthur Gensler Jr. & Associates, Inc. Marriott International, Inc. Mars, Incorporated Marsh & McLennan Companies Massachusetts Association of Health Plans Massachusetts Mutual Life Insurance Co. Mattson The McGraw-Hill Companies McKinstry Co. Microsoft Corporation Moody's Corporation Morgan Stanley Mosaic Financial Partners, Inc. MultiPlan, Inc. Neumann Capital Management, LLC New York Life Insurance Company NIKE, Inc. The Ogilvy Group, Inc. The Olivia Companies, LLC 1 Source Consulting Solutions Onyx Pharmaceuticals, Inc. Oracle America, Inc. Orbitz Worldwide Partners HealthCare System, Inc. Paul's Draperies, Inc. Pfizer Inc. Pierson Labs Planet Fitness Precision Door Service The PrintingWorks Prior Construction Pro-Tec Data, Inc. ProTrials Research, Inc. Puma Spring Vineyards Qualcomm Incorporated Ray Holley Communications Recreational Equipment, Inc. (REI) Regroup Reproductive Science Center of New England, P.C. Resource Systems Group, Inc. (RSG) Rising Tide Brewing Company RLL Consulting & Advocacy, LLC Rocket Science Associates Rural Communications Service Corporation salesforce.com, Inc. Seabold International Services LLC Seattle Hospitality Group LLC The Seattle Lesbian, LLC Shawmut Design and Construction Silicon Valley Progressive Faith Community Sing Out Louise! Productions Smith & Quinn LLC Solutions Wealth Management, LLC Sōw Starbucks Corporation State Street Corporation Stone Way Eateries, LLC Stonyfield Farm, Inc. Stuffed Cakes, LLC Sun Life Financial (U.S.) Service Stonyfield Farm, Inc. Stuffed Cakes, LLC Sun Life Financial (U.S.) Services Company, Inc. Support.com Sweet Taber Food Services, Inc. Thomson Reuters Total Awareness Accounting Services Total Home Improvement Inc. Transparent Language, Inc. Twitter, Inc. 206 Inc. UBS AG U.S. Balloon Co. The Ultimate Software Group, Inc. Unigo LLC VCB Consulting & Accounting Services Velsch Unlimited LLC Verity Credit Union Viacom Inc. VitalSource Staffing, LLC Vulcan Inc. W/S Development Associates LLC Walt Disney Company Wasserman Media Group Windows Management Experts, Inc. Witeck Communications, Inc. Xerox Corporation Zynga Inc. Law and professional firms: A.L. Nella & Company, LLP, CPAs Axcel Law Partners LLP Baker & McKenzie LLP Burns & Levinson LLP Choate Hall & Stewart LLP Davis, Brown, Koehn, Shors & Roberts, P.C. DLK Law Group, P.C. Edwards Wildman Palmer LLP Farella Braun + Martel, LLP Fenwick & West LLP Goulston & Storrs, P.C. Grippo & Elden LLC Heath-Newton LLP Hughes Hubbard & Reed LLP Integrity Law Group Jennifer Brown Consulting Jonathan L. Bowman, Attorney at Law, PS Kazan, McClain, Satterley, Lyons, Greenwood & Oberman, PLC Keker & Van Nest LLP Lafayette & Kumagai LLP Law Office of Lisa E. Schuchman The Law Office of Susan K. Fuller, PLLC Law Offices of Cynthia F. Buhr PLLC Lieff Cabraser Heimann & Bernstein, LLP Mona Smith PLLC Nixon Peabody LLP Peabody & Arnold LLP Prince Lobel Tye LLP Public Interest Law Group, PLLC Ropes & Gray LLP Russell & Olson, LLP Salera Consulting Seyfarth Shaw LLP Shearman & Sterling LLP Skadden, Arps, Slate, Meagher & Flom LLP Skellenger Bender, P.S. Spectra Law PS Valdez Noor Todd & Doyle LLP Venable LLP Willkie Farr & Gallagher LLP Professional, trade, and civic organizations: American Benefits Council Connecticut Alliance for Business Opportunities Golden Gate Restaurant Association Greater Boston Chamber of Commerce Greater San Diego Business Association Greater Seattle Business Association Long Beach Community Business Network Massachusetts Teachers Association The National Fire Protection Association, Inc. National Gay and Lesbian Chamber of Commerce Out & Equal Workplace Advocates Portland Area Business Association Rainbow Chamber of Commerce Silicon Valley San Francisco Chamber of Commerce Seattle Metropolitan Chamber of Commerce StartOut and Cities, Counties and the United States Conference of Mayors: The City of Baltimore, Maryland The City of Bangor, Maine The City of Boston, Massachusetts The City of Cambridge, Massachusetts The City of Hartford, Connecticut The City of Healdsburg, California The City of Los Angeles, California The City of New York, New York, and the Council of the City of New York, New York The City of Northampton, Massachusetts The City of Portsmouth, New Hampshire The City of Providence, Rhode Island The City and County of San Francisco, California The City of Santa Monica, California The City of Seattle, Washington The City of West Hollywood, California The County of King, Washington The County of Santa Clara, California The United States Conference of Mayors -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

02 августа 2015, 18:00

Третья промышленная революция

Снаружи широко раскинувшегося Frankfurt Messe, приюта для бесчисленных немецких торговых выставок, стоит «Человек с молотком», 21-метровая кинетическая статуя, которая постоянно поднимает и опускает свою руку, ударяя по куску металла молотом. Джонатан Борофски, построивший «Человека» скульптор, говорит, что «Человек» чествует рабочего, создавшего с помощью разума и рук окружающий нас мир. Это знакомая история. Но сегодня методы производства меняются с помощью ряда примечательных способов, […]

24 июля 2015, 18:07

Biogen Tops Q2 Earnings, Cuts View on Tecfidera Issues - Analyst Blog

Although Biogen's (BIIB) second quarter earnings surpassed expectations, the revenue miss and lowered outlook is disappointing.

Выбор редакции
23 июля 2015, 14:59

Лекарство на основе антител замедлило развитие болезни Альцгеймера

Американские фармацевты объявили о создании первого эффективного препарата против болезни Альцгеймера, атакующего сразу все типы бляшек в мозге пациентов. Это помогает замедлить деградацию когнитивных функций при заболевании.

23 июля 2015, 12:05

How Pharma Can Offer More than Pills

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” —  in other words, to build and deploy complementary services and solutions to diversify revenue sources. The rationale is simple and elegant: A company with experience selling pharmaceutical products should be able to successfully and profitably sell its large customers (health plans, delivery systems, and governments) other health care offerings. The impetus to move beyond the pill typically arises from one or two realizations: 1) medicines alone are often not enough for patients to achieve optimal clinical outcomes, and 2) as pharmaceutical pipelines dry up, beyond-the-pill businesses can be valuable new sources of revenues. However, many beyond-the-pill efforts have sputtered or died. During my years working as a pharmaceutical industry executive and advisor to senior management, I have observed that these initiatives typically fail because of one of three challenges: Leadership. Many pharmaceutical companies make the mistake of transitioning outstanding leaders from their sales operations to head their beyond-the-pill businesses.  However talented they might be, these individuals often lack experience building non-pharma service businesses. In addition, pharma companies occasionally acquire new services and solutions companies and try to integrate them. These integrated businesses are also typically led by pharma managers who don’t fully understand the acquired businesses and their markets. Regulatory environment. One perceived asset in launching new beyond-the-pill businesses is existing customer relationships with large payers, health systems, and physician groups. While these relationships certainly help to open doors, anti-kickback statutes require pharma companies to document and charge back the fair-market value of any added services or solutions delivered to customers of its pharmaceutical products. This requirement is a strain with which entrepreneurial competitors outside the pharma industry do not have to contend. In addition, many top pharma customers (payers, etc.) also sell health care services and solutions. As a result, pharma companies occasionally ends up competing for business with their most important customers. Access to capital. Capital to build and grow diversified new businesses is scarce — particularly in publicly traded companies that have obligations to shareholders. All things being equal, when boards, CEOs, and executive committees allocate capital, they are more likely to support and develop a molecule that could yield a billion-dollar annual annuity or enhance the sales of an existing molecule than enter an unfamiliar business whose margins are much smaller and whose long-term business prospects are less clear. Consequently, beyond-the-pill initiatives often start auspiciously with generous seed funding only to lose ground in later rounds of capital allocation when new scientific projects with higher potential returns must be funded. Pharmaceutical companies can give flight to beyond-the-pill initiatives by recognizing the long history of false starts and proactively avoiding repeating mistakes associated with them. Here’s how: Recruit industry outsiders. The talent and skill needed to build and market services and solutions is different from the talent required to market drugs. So when pharma companies select leaders for the new undertakings, they should strongly consider recruiting new talent from outside the industry. For example, when Sanofi created its new chief patient officer function to build solutions that matter most to patients, it recruited Anne Beal, a physician who has been deeply involved in efforts to reform U.S. health care, to fill the role. Form partnerships. When possible, companies should avoid building their own solutions or acquiring any other companies. Instead, they should partner with other companies — something Novartis recently did this when it launched a $100 million investment fund with technology giant Qualcomm. Partner companies can bring an external perspective on the solutions landscape and provide capabilities that pharma companies would have difficulty building themselves. Revise regulations. Anti-kickback statutes were the product of an era when financial payments were given to physicians and hospital systems in exchange for prescribing. With the emergence of digital health tools and the health care industry’s focus on value, these regulations require some rethinking and new industry guidance. Pharma companies should seek a new regulatory framework by proactively engaging in the United States with the Office of the Inspector General, Food and Drug Administration, and the Centers for Medicare and Medicaid Services. Avoid standalone solutions. Any new services or solutions should be supportive of the core pharmaceutical business and not compete with it for capital or management attention. So rather than trying to build beyond-the-pill solutions that are decoupled from their core pharmaceutical products, companies should strive to enhance the effectiveness of their own medicines with tightly linked complementary services, solutions, and tools that encourage patients to be more engaged in their own care and help them adhere to their prescribed therapies. Integrated clinical trials. Pharma companies should consider integrating beyond-the-pill solutions into clinical trials so that they can eventually sell services and drugs together as a packaged offering. A progenitor to these types of clinical trials was Biogen Idec’s recent study of the use of Fitbit devices to monitor multiple sclerosis management and progression. By pairing medicines with wrap-around solutions within a clinical trial setting, companies can differentiate their offerings and generate additional revenues — particularly in chronic disease categories where patient engagement is critical to achieving better outcomes. Medicines could accordingly reach market with a label that includes an “around the pill” solution such as a wearable or another tracking device. The world will continue to need companies that develop and commercialize new medicines. Those same companies must not lose sight of this fact and recruit the right leadership to use around-the-pill services, solutions, and tools to enhance the clinical effectiveness and commercial success of their core products.

06 июля 2015, 22:58

Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead - Stocks in the News

Biogen has been underperforming lately, consider these biotech stocks instead.

06 июля 2015, 07:39

Порошенко разрешил немецким фармацевтическим кампаниям ставить опыты на украинцах

На прошлой неделе министр здравоохранения Украины Александр Квиташвили подал в отставку после разразившегося скандала с дефицитом лекарственных средств в аптеках и лечебных учреждениях.

Выбор редакции
03 июля 2015, 21:00

Applied Genetic Up on Biogen Deal for Eye Disease Drugs - Analyst Blog

Applied Genetic Technologies Corporation (AGTC) announced a collaboration and license agreement with Biogen (BIIB) for the development of gene-based therapies for multiple ophthalmic diseases.

Выбор редакции
01 июля 2015, 22:50

Bayer Files Hemophilia A Drug Marketing Application in Japan - Analyst Blog

The HealthCare segment at Bayer (BAYRY) announced that the company has submitted a Marketing Authorization Application in Japan for BAY 81-8973.

01 июля 2015, 18:29

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

Immunotherapy continues to be a hot therapeutic area with Celgene (CELG) shelling out at least $1B to collaborate with Juno (JUNO).

29 июня 2015, 23:35

Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog

Biogen (BIIB) and partner Swedish Orphan Biovitrum's hemophilia B drug, Alprolix, is under review in the EU.

25 июня 2015, 22:25

Transition Therapeutics Tanks on Alzheimer's Disease Data - Analyst Blog

Transition Therapeutics (TTHI) saw its shares plunge 74.1% after its Alzheimer's disease candidate, ELND005, failed in a phase II/III study.

23 июня 2015, 22:45

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

Isis Pharmaceuticals, Inc.'s (ISIS) ISIS-SMNRx led to continued and durable increase in muscle function in an extension study for spinal muscular atrophy in children.